IL269853A - Proteins for the treatment of epithelial barrier activity disorders - Google Patents
Proteins for the treatment of epithelial barrier activity disordersInfo
- Publication number
- IL269853A IL269853A IL26985319A IL26985319A IL269853A IL 269853 A IL269853 A IL 269853A IL 26985319 A IL26985319 A IL 26985319A IL 26985319 A IL26985319 A IL 26985319A IL 269853 A IL269853 A IL 269853A
- Authority
- IL
- Israel
- Prior art keywords
- proteins
- treatment
- barrier function
- epithelial barrier
- function disorders
- Prior art date
Links
- 230000004890 epithelial barrier function Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Prostheses (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762482963P | 2017-04-07 | 2017-04-07 | |
| US201762607706P | 2017-12-19 | 2017-12-19 | |
| US201762611334P | 2017-12-28 | 2017-12-28 | |
| PCT/US2018/026447 WO2018187682A1 (en) | 2017-04-07 | 2018-04-06 | Proteins for the treatment of epithelial barrier function disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL269853A true IL269853A (en) | 2019-11-28 |
Family
ID=63710147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL26985319A IL269853A (en) | 2017-04-07 | 2019-10-06 | Proteins for the treatment of epithelial barrier activity disorders |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10251933B2 (https=) |
| EP (1) | EP3606542A4 (https=) |
| JP (2) | JP7789303B2 (https=) |
| KR (2) | KR20200003821A (https=) |
| CN (1) | CN110769844B (https=) |
| AU (2) | AU2018248324B2 (https=) |
| CA (1) | CA3059354A1 (https=) |
| IL (1) | IL269853A (https=) |
| MX (2) | MX393998B (https=) |
| SG (1) | SG11201909334TA (https=) |
| TW (1) | TWI797116B (https=) |
| WO (1) | WO2018187682A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10251933B2 (en) * | 2017-04-07 | 2019-04-09 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11666627B2 (en) | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| EP3773644A4 (en) * | 2018-04-06 | 2021-06-02 | Second Genome, Inc. | PROTEINS FOR TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS |
| CN113347983A (zh) * | 2018-10-09 | 2021-09-03 | 第二基因组股份有限公司 | 用于递送有效治疗上皮屏障功能障碍的蛋白质的乳酸乳球菌表达系统 |
| US20210079086A1 (en) * | 2019-08-21 | 2021-03-18 | Astrazeneca Collaboration Ventures, Llc | Use of Brazikumab to Treat Crohn's Disease |
| US11666629B2 (en) * | 2020-01-10 | 2023-06-06 | National Taipei University Of Technology | Peptide interacting with toll-like receptor 2 and the composition comprising the same |
| CN113773364B (zh) * | 2021-08-25 | 2023-04-28 | 无锡市儿童医院 | 小分子肽及其制备方法和应用 |
| CN120882418A (zh) * | 2022-11-04 | 2025-10-31 | MiNK治疗公司 | B细胞成熟抗原(bcma)嵌合抗原受体不变自然杀伤t细胞及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5571702A (en) | 1991-03-29 | 1996-11-05 | Genentech, Inc. | Amplification method for detection of human PF4A receptors |
| AR053579A1 (es) * | 2005-04-15 | 2007-05-09 | Genentech Inc | Tratamiento de la enfermedad inflamatoria intestinal (eii) |
| DK3061766T3 (da) * | 2009-04-28 | 2020-03-16 | Univ Vanderbilt | Sammensætninger og fremgangsmåder til behandlingen af sygdomme der involverer epitelcelleapoptose |
| GB201117313D0 (en) * | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| JP2014093482A (ja) | 2012-11-06 | 2014-05-19 | Toshiba Corp | 固体撮像装置の製造方法および固体撮像装置 |
| GB201306536D0 (en) * | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| WO2015014973A2 (en) * | 2013-07-31 | 2015-02-05 | Institut National De La Recherche Agronomique | Use of specific glycoside phosphorylases for the implementation of phosphorolysis or reverse phosphorolysis reactions |
| WO2016203221A1 (en) * | 2015-06-15 | 2016-12-22 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| US10251933B2 (en) | 2017-04-07 | 2019-04-09 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11666627B2 (en) * | 2017-04-07 | 2023-06-06 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
| US11174293B2 (en) | 2017-06-02 | 2021-11-16 | Second Genome, Inc. | Proteins for the treatment of epithelial barrier function disorders |
-
2018
- 2018-04-06 US US15/947,263 patent/US10251933B2/en active Active
- 2018-04-06 CA CA3059354A patent/CA3059354A1/en active Pending
- 2018-04-06 SG SG11201909334T patent/SG11201909334TA/en unknown
- 2018-04-06 MX MX2019012051A patent/MX393998B/es unknown
- 2018-04-06 EP EP18781398.5A patent/EP3606542A4/en active Pending
- 2018-04-06 KR KR1020197032830A patent/KR20200003821A/ko not_active Ceased
- 2018-04-06 WO PCT/US2018/026447 patent/WO2018187682A1/en not_active Ceased
- 2018-04-06 JP JP2019554976A patent/JP7789303B2/ja active Active
- 2018-04-06 AU AU2018248324A patent/AU2018248324B2/en active Active
- 2018-04-06 CN CN201880037987.0A patent/CN110769844B/zh not_active Expired - Fee Related
- 2018-04-06 US US16/603,507 patent/US11207376B2/en active Active
- 2018-04-06 KR KR1020237032575A patent/KR102903277B1/ko active Active
- 2018-04-09 TW TW107112165A patent/TWI797116B/zh active
-
2019
- 2019-10-06 IL IL26985319A patent/IL269853A/en unknown
- 2019-10-07 MX MX2022008842A patent/MX2022008842A/es unknown
-
2023
- 2023-04-24 US US18/305,899 patent/US20240066095A1/en active Pending
- 2023-05-08 AU AU2023202844A patent/AU2023202844A1/en not_active Abandoned
- 2023-12-11 JP JP2023208379A patent/JP2024037834A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR102903277B1 (ko) | 2025-12-23 |
| US20240066095A1 (en) | 2024-02-29 |
| US20180289770A1 (en) | 2018-10-11 |
| MX393998B (es) | 2025-03-24 |
| US20200148728A1 (en) | 2020-05-14 |
| AU2023202844A1 (en) | 2023-07-06 |
| CN110769844B (zh) | 2025-01-21 |
| US11207376B2 (en) | 2021-12-28 |
| CA3059354A1 (en) | 2018-10-11 |
| TW201841649A (zh) | 2018-12-01 |
| KR20230144097A (ko) | 2023-10-13 |
| EP3606542A1 (en) | 2020-02-12 |
| MX2019012051A (es) | 2020-02-12 |
| TWI797116B (zh) | 2023-04-01 |
| JP7789303B2 (ja) | 2025-12-22 |
| US10251933B2 (en) | 2019-04-09 |
| JP2020516615A (ja) | 2020-06-11 |
| JP2024037834A (ja) | 2024-03-19 |
| AU2018248324A1 (en) | 2019-10-31 |
| WO2018187682A1 (en) | 2018-10-11 |
| AU2018248324B2 (en) | 2023-02-09 |
| CN110769844A (zh) | 2020-02-07 |
| KR20200003821A (ko) | 2020-01-10 |
| SG11201909334TA (en) | 2019-11-28 |
| MX2022008842A (es) | 2022-08-02 |
| EP3606542A4 (en) | 2021-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289650A (en) | Azolopyrimidine for the treatment of cancer-related disorders | |
| IL285151A (en) | Methods of treating fgf21-associated disorders | |
| IL275482A (en) | Asketamine for the treatment of depression | |
| GB2572126B (en) | Pharmaceutical | |
| GB2569961B (en) | Pharmaceutical | |
| GB2572125B (en) | Pharmaceutical | |
| IL269853A (en) | Proteins for the treatment of epithelial barrier activity disorders | |
| PL3618829T3 (pl) | Pochodne chinazolinopirydyny do leczenia zaburzeń związanych z nowotworem | |
| PL3634417T3 (pl) | Pochodne chinazolino-pirazolowe do leczenia chorób związanych z nowotworem | |
| EP3227330A4 (en) | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases | |
| EP3256218A4 (en) | Kdm1a inhibitors for the treatment of disease | |
| IL256077A (en) | Fragments of mutated ras protein | |
| IL259281B (en) | History of bipyrazolyl used in the treatment of autoimmune diseases | |
| IL270543A (en) | Treatment methods for recurrent glioblastoma (RGBM) | |
| PL3452075T3 (pl) | Oftalmiczna kompozycja farmaceutyczna | |
| EP3348273B8 (en) | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders | |
| EP3256158A4 (en) | Tolerance therapeutic for treating polypeptide induced allergy | |
| PL3448340T3 (pl) | Pomocniczy element aplikacyjny do opatrywania ran | |
| ZA201902689B (en) | Therapeutic protein | |
| IL283273A (en) | Pharmacy practices | |
| ZA201901505B (en) | Phenylalanine-free protein for the treatment of pku | |
| MA54630A (fr) | N,n-bis-2-mercaptoéthyle isophtalamide pour le traitment des maladies neurodégénératives | |
| EP3507277B8 (en) | Hydroxynorketamine derivatives for the treatment of disorders | |
| HK40047137A (en) | Proteins for the treatment of epithelial barrier function disorders | |
| HK40025989A (en) | Methods of treating neuropsychiatric disorders |